210 related articles for article (PubMed ID: 28116650)
1. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
4. Surgery for primary central nervous system lymphoma: is it time for reevaluation?
Bierman PJ
Oncology (Williston Park); 2014 Jul; 28(7):632-7. PubMed ID: 25144286
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
7. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
[TBL] [Abstract][Full Text] [Related]
8. The role of surgery in intracranial PCNSL.
Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
[TBL] [Abstract][Full Text] [Related]
9. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
[TBL] [Abstract][Full Text] [Related]
10. The role of surgery in primary central nervous system lymphomas.
Villalonga JF; Alessandro L; Farez MF; Mormandi R; Cervio A; Alcorta SC; Muggeri A
Arq Neuropsiquiatr; 2018 Mar; 76(3):139-144. PubMed ID: 29809232
[TBL] [Abstract][Full Text] [Related]
11. Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
Lin TK; Yeh TH; Hsu PW; Chuang CC; Tu PH; Chen PY; Jung SM; Wei KC; Huang YC
World Neurosurg; 2017 Jul; 103():550-556. PubMed ID: 28363832
[TBL] [Abstract][Full Text] [Related]
12. Resection versus biopsy for management of primary central nervous system lymphoma: a meta-analysis.
Stifano V; Della Pepa GM; Offi M; Montano N; Carcagnì A; Pallini R; Lauretti L; Olivi A; D'Alessandris QG
Neurosurg Rev; 2023 Jan; 46(1):37. PubMed ID: 36645525
[TBL] [Abstract][Full Text] [Related]
13. Surgery for primary CNS lymphoma? Challenging a paradigm.
Weller M; Martus P; Roth P; Thiel E; Korfel A;
Neuro Oncol; 2012 Dec; 14(12):1481-4. PubMed ID: 22984018
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
Lin FH; Zhang XH; Zhang J; He ZQ; Duan H; Ke C; Sai K; Jiang XB; Al-Nahari F; Xi SY; Mou YG
J Neurooncol; 2018 Sep; 139(3):757-765. PubMed ID: 30117022
[TBL] [Abstract][Full Text] [Related]
15. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis.
Yun J; Yang J; Cloney M; Mehta A; Singh S; Iwamoto FM; Neugut AI; Sonabend AM
Front Neurol; 2017; 8():478. PubMed ID: 28955300
[TBL] [Abstract][Full Text] [Related]
17. Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.
Kinslow CJ; Rae AI; Neugut AI; Adams CM; Cheng SK; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Iwamoto FM; Sonabend AM; Wang TJC
Br J Neurosurg; 2020 Dec; 34(6):690-696. PubMed ID: 31931632
[No Abstract] [Full Text] [Related]
18. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma.
Evers G; Kamp M; Warneke N; Berdel W; Sabel M; Stummer W; Ewelt C
World Neurosurg; 2017 Feb; 98():375-380. PubMed ID: 27838426
[TBL] [Abstract][Full Text] [Related]
20. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]